Hantech Bio-Technology Future Growth
Future criteria checks 1/6
Hantech Bio-Technology is forecast to grow revenue at 13.7% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Personal Products earnings growth | 17.9% |
| Revenue growth rate | 13.7% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 29 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 943 | N/A | 40 | 190 | 1 |
| 12/31/2024 | 805 | N/A | -62 | 138 | 1 |
| 6/30/2024 | 775 | 179 | -128 | 144 | N/A |
| 3/31/2024 | 725 | 174 | -103 | 174 | N/A |
| 12/31/2023 | 625 | 148 | -105 | 192 | N/A |
| 12/31/2022 | 303 | 47 | -20 | 63 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 1294's forecast earnings growth is above the savings rate (1.1%).
Earnings vs Market: Insufficient data to determine if 1294's earnings are forecast to grow faster than the TW market
High Growth Earnings: Insufficient data to determine if 1294's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 1294's revenue (13.7% per year) is forecast to grow faster than the TW market (12.6% per year).
High Growth Revenue: 1294's revenue (13.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 1294's Return on Equity is forecast to be high in 3 years time